BNP Paribas Financial Markets’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Sell
5,375
-2,092
-28% -$81K ﹤0.01% 4177
2026
Q1
$281K Buy
7,467
+526
+8% +$17.2K ﹤0.01% 3894
2025
Q4
$209K Sell
6,941
-57,693
-89% -$1.63M ﹤0.01% 4036
2025
Q3
$1.7M Buy
64,634
+63,533
+5,770% +$1.51M ﹤0.01% 2731
2025
Q2
$23.5K Buy
1,101
+801
+267% +$18.1K ﹤0.01% 4531
2025
Q1
$6.38K Sell
300
-1,520
-84% -$31.2K ﹤0.01% 4807
2024
Q4
$36.9K Buy
+1,820
New +$37.6K ﹤0.01% 4543

Other funds holding GRDN

BNP Paribas Financial Markets's GRDN Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Guardian Pharmacy Services (GRDN) stake by 28% in Q2 2026, selling an estimated $81K and leaving 5,375 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #4177.

BNP Paribas Financial Markets first reported a position in GRDN in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.7M in Q3 2025. 173 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • BNP Paribas Financial Markets held 5,375 shares of Guardian Pharmacy Services worth $225K as of Q2 2026.
  • BNP Paribas Financial Markets sold 2,092 Guardian Pharmacy Services shares in Q2 2026, an estimated $81K.
  • Guardian Pharmacy Services made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4177 holding.
  • BNP Paribas Financial Markets first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Guardian Pharmacy Services position peaked at $1.7M in Q3 2025.
  • 173 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.